| http://www.w3.org/ns/prov#value | - Administering the novel compounds causes a decrease in one or more specific proinflammatory proteins, including Il-1, IL-2, Il-8, and TNF-??, which have been associated with tissue and organ damage in diseases such as rheumatoid arthritis, osteoarthritis, other autoimmune disorders, transplant rejection, and cancers.
|
